Welcome to Guo Lab

Welcome to the Guo Lab at Vanderbilt University Medical Center (VUMC)! Our Principal Investigator, Xingyi Guo, PhD, is a tenured Associate Professor of Medicine, an NCI R37 MERIT Awardee, and a recipient of the Rawlings Directorship at Vanderbilt-Ingram Cancer Center and the Francis and William Blot Research Award. Our interdisciplinary research integrates bioinformatics, statistical genetics, genetic and molecular epidemiology, multi-omics, artificial intelligence, computational biology, digital pathology, and electronic health records (EHRs). We investigate common, rare, and structural genetic variants; single-cell and spatial omics; and H&E histopathology to advance understanding of colorectal cancer, colorectal adenoma, and inflammatory bowel disease and to develop precision prevention and intervention strategies.

Bioinformatics & biostatistics & AI
Statistical genetics
Multi-omics (single-cell & spatial)
EHR phenotyping
Drug repurposing

News & Updates editable

Tool released

GLMM to detect risk TFs • sTF-TWAS • transTF-TWAS.

We’re recruiting

Openings for trainees and collaborators (see “Join”).

Research

The Guo Lab investigates the genetic and molecular mechanisms underlying human cancers and gastrointestinal diseases, particularly colorectal cancer (CRC), colorectal adenoma, and inflammatory bowel disease (IBD). We develop and apply statistical, bioinformatics, and machine-learning/deep-learning methods to integrate large-scale GWAS, whole-genome sequencing, common and rare variants, structural variants, transcriptomics, epigenomics, proteomics, single-cell and spatial omics, hematoxylin and eosin (H&E) histopathology images, and longitudinal electronic health records (EHRs). Our work spans susceptibility gene and protein discovery, cell-type-specific regulatory mechanisms, disease progression and recurrence, multimodal AI risk prediction, and translation to therapeutic targets and drug repurposing. Our NCI-supported research includes R37CA227130 (MERIT), R01CA269589, and R01CA297582.

1) Statistical genetics & genomic variation

Discover susceptibility factors and characterize the effects of common, rare, and structural genetic variants across populations.

  • GWAS, whole-genome sequencing, and fine-mapping
  • Rare-variant and structural-variant association analyses
  • Cross-ancestry genetics and risk prediction

2) Multi-omics & functional genomics

Integrate molecular and cellular data to prioritize susceptibility genes, proteins, and regulatory mechanisms.

  • TWAS, PWAS, and integrative multi-omics
  • Single-cell and spatial transcriptomics / epigenomics
  • Cell-type-specific regulatory networks and functional annotation

3) Colorectal adenoma & cancer progression

Study colorectal adenoma susceptibility, recurrence, and progression to support precision cancer prevention.

  • Large-scale genetic and molecular epidemiology
  • EHR-linked cohorts and longitudinal outcomes
  • Adenoma recurrence and colorectal cancer risk stratification

4) Multimodal AI, digital pathology & translation

Combine molecular, pathological, and clinical evidence to improve prediction and therapeutic discovery.

  • H&E histopathology and computational pathology
  • Multimodal AI integrating genomics, omics, images, and EHRs
  • Real-world evidence, target prioritization, and drug repurposing

Research Highlights

Selected figures illustrating recent projects and methods.

Tools & Resources

We build and maintain software for statistical analysis to improve discovery of risk genes and transcription factors.

TF-TWAS suite R

GLMM for risk TF detection • sTF-TWAS • transTF-TWAS.

GitHub →

PQTL_EHR framework Workflow

Integrates cancer GWAS, proteomics, and EHRs to identify druggable proteins and therapeutic candidates.

Repository →

Colorectal adenoma GWAS Dataset

Resources and summary results.

Request access →

Team

Current members.

Xingyi Guo profile photo
PI: Xingyi Guo, PhD Principal Investigator
Jifeng Wang profile photo
Jifeng Wang, PhD Staff ScientistResearch: Cancer biology
Qing Li profile photo
Qing Li, PhD Postdoctoral FellowResearch: Statistical genetics and multi-omics
Chao Li profile photo
Chao Li Graduate StudentResearch: Genetic epidemiology and multi-omics
Linshuoshuo Lyu profile photo
Linshuoshuo Lyu Graduate StudentResearch: Genetic epidemiology and real-world data
Eugene Jeong, PhD T32 Postdoctoral FellowResearch: Artificial intelligence and multi-omics
Joshua Ye InternResearch: Artificial intelligence and multi-omics
Yuan Zhou profile photo
Yuan Zhou, PhD Postdoctoral FellowResearch: Statistical genetics and artificial intelligence
Fangcheng Yuan profile photo
Fangcheng Yuan, PhD Postdoctoral FellowResearch: Molecular and genetic epidemiology and multi-omics
Jungyoon Choi profile photo
Jungyoon Choi, MD, PhD Visiting ScholarResearch: Colorectal oncology and cancer epidemiology
Alumni See all alumni

Publications

Selected publications from the Guo Lab (* corresponding author).

  1. Multi-ancestry genome-wide and transcriptome-wide association analyses identify new risk loci and genes for inflammatory bowel disease.
    Lyu L, Li Q, Li C, Dawwas GK, Chen Y, Tao R, Liu Q, Wen W, Shu XO, Washington K, Schwartz DA, Zheng W, Yin Z, Lau KS, Guo X*.
    Nature Communications. 2026. DOI: 10.1038/s41467-026-79302-1
  2. Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer prevention.
    Li Q, Song Q, Chen Z, Choi J, Moreno V, Ping J, Wen W, Li C, Shu X, Yan J, Shu XO, Cai Q, Long J, Huyghe JR, Pai R, Gruber SB, Yang Y, Casey G, Wang X, Toriola AT, Li L, Singh B, Lau KS, Zhou L, Zhang Z, Wu C, Peters U, Zheng W, Long Q*, Yin Z*, Guo X*.
    Am J Hum Genet. 2026 Jan 8;113(1):41-56. doi: 10.1016/j.ajhg.2025.11.008. Epub 2025 Dec 2. PMID: 41338217.
  3. Demographic and Clinicopathologic Factors Associated with Colorectal Adenoma Recurrence.
    Awan UA, Song Q, Ciombor KK, Toriol AT, Choi J, Su T, Shu XO, Idrees K, Washington KM, Zheng W, Wen W*, Yin Z*, Guo X*.
    JAMA Network Open. 2026. (Preprint: 2025 May 3:2025.03.28.25324826.) doi: 10.1101/2025.03.28.25324826. PMID: 40343045.
  4. Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility.
    Chen Z, Song W, Li Q, many others, Guo X*.
    Nature Communications. 2026. PMID: 41540004 PMCID: PMC12877115 DOI: 10.1038/s41467-025-68127-z
  5. Enhancing disease risk gene discovery by integrating transcription factor-linked trans-variants into transcriptome-wide association analyses.
    He J, Perera D, Wen W, Ping J, Li Q, Lyu L, Chen Z, Shu X, Long J, Cai Q, Shu XO, Yin Z, Zheng W, Long Q*, Guo X*.
    Nucleic Acids Res. 2025 Jan 7;53(1):gkae1035. doi: 10.1093/nar/gkae1035. PMID: 39535029.
  6. Large-Scale Alternative Polyadenylation-Wide Association Studies to Identify Putative Cancer Susceptibility Genes.
    Guo X*, Ping J, Yang Y, Su X, Shu XO, Wen W, Chen Z, Zhang Y, Tao R, Jia G, He J, Cai Q, Zhang Q, Giles GG, Pearlman R, Rennert G, Vodicka P, Phipps A, Gruber SB, Casey G, Peters U, Long J, Lin W*, Zheng W*.
    Cancer Res. 2024 Aug 15;84(16):2707-2719. doi: 10.1158/0008-5472.CAN-24-0521. PMID: 38759092.
  7. Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation.
    Chen Z, Song W, many others, Guo X*.
    J Natl Cancer Inst. 2024 Jan 10;116(1):127-137. doi: 10.1093/jnci/djad178. PMID: 37632791.
  8. Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer.
    Holowatyj AN*, Wen W, Gibbs T, Seagle HM, Keller SR, Edwards DRV, Washington MK, Eng C, Perea J, Zheng W, Guo X*.
    Cancer Discov. 2023 Mar 1;13(3):570-579. doi: 10.1158/2159-8290.CD-22-0764. PMID: 3652063.
  9. Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers.
    He J, Wen W, Beeghly A, Chen Z, Cao C, Shu XO, Zheng W, Long Q*, Guo X*.
    Nat Commun. 2022 Nov 19;13(1):7118. doi: 10.1038/s41467-022-34888-0. PMID: 36402776.
  10. Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer.
    Choi J, Holowatyj AN, Du M, Chen Z, Wen W, Schultz N, Lipworth L, Guo X*.
    JCO Precis Oncol. 2022 Feb;6:e2100401. doi: 10.1200/PO.21.00401. PMID: 35108035.
  11. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
    Wen W*, Chen Z, Bao J, Long Q, Shu XO, Zheng W, Guo X*.
    Nat Commun. 2021 Sep 13;12(1):5318. doi: 10.1038/s41467-021-25670-9. PMID: 34518541.
  12. Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.
    Guo X*, many others.
    Gastroenterology. 2021 Mar;160(4):1164-1178.e6. doi: 10.1053/j.gastro.2020.08.062. PMID: 33058866.
  13. Spectrum of Somatic Cancer Gene Variations Among Adults With Appendiceal Cancer by Age at Disease Onset.
    Holowatyj AN*, Eng C, Wen W, Idrees K, Guo X*.
    JAMA Netw Open. 2020 Dec 1;3(12):e2028644. doi: 10.1001/jamanetworkopen.2020.28644. PMID: 33295976.
  14. Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human Cancers.
    Chen Z, Wen W, Beeghly-Fadiel A, Shu XO, Díez-Obrero V, Long J, Bao J, Wang J, Liu Q, Cai Q, Moreno V, Zheng W, Guo X*.
    Am J Hum Genet. 2019 Sep 5;105(3):477-492. doi: 10.1016/j.ajhg.2019.07.006. PMID: 31402092.
  15. Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.
    Guo X*, Long J, Chen Z, Shu XO, Xiang YB, Wen W, Zeng C, Gao YT, Cai Q, Zheng W.
    Int J Cancer. 2020 Apr 15;146(8):2175-2181. doi: 10.1002/ijc.32825. PMID: 31837001.
  16. Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genes.
    Guo X*, Shi J, Cai Q, Shu XO, He J, Wen W, Allen J, Pharoah P, Dunning A, Hunter DJ, Kraft P, Easton DF, Zheng W, Long J.
    Hum Mol Genet. 2018 Mar 1;27(5):853-859. doi: 10.1093/hmg/ddy005. PMID: 29325031.
  17. A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.
    Guo X*, Lin W, Bao J, Cai Q, Pan X, Bai M, Yuan Y, Shi J, Sun Y, Han MR, Wang J, Liu Q, Wen W, Li B, Long J, Chen J, Zheng W.
    Am J Hum Genet. 2018 May 3;102(5):890-903. doi: 10.1016/j.ajhg.2018.03.016. PMID: 29727689.

Join the Lab

We welcome motivated trainees and collaborators. If you’re interested, please email a CV and a short description of your interests, preferred start date, and relevant experience.

Open roles for PhD students/postdocs

  • Bioinformatics, Statistics, Computer Science
  • Genomics, Multi-omics, EHR methods
  • Analytical Pipelines, Cancer Biology

What to include

  • CV + links (e.g., GitHub)
  • 1–2 paragraphs: your interests & fit
  • Example projects or papers

Contact

Email

xingyi.guo@vumc.org

(For prospective trainees: please include your CV and availability.)

Address

Departments of Medicine & Biomedical Informatics
Vanderbilt University Medical Center
2525 West End Ave
Nashville, TN 37203